Biora Year-End Report 2002

Year End Report 2002 Biora AB (publ) February 13, 2003 4th Qtr 4th Qtr Full Year Full Year 2002 2001 2002 2001 Net sales, SEK million 30.2 32.9 129.7 110.7 Operating result, SEK million 0.5 0.2 -0.9 -26.5 Net result, SEK million 1.2 0.6 0.7 -25.1 · Net result for 2002 was a profit of SEK 0.7 million (compared to a net loss of SEK 25.1 million for 2001). · Sales during 2002 increased by 17 percent to SEK 129.7 million (compared to SEK 110.7 million for 2001). · Sales during the fourth quarter of 2002 amounted to SEK 30.2 million (compared to SEK 32.9 million for the fourth quarter of 2001). · Significant negative impact on sales for 2002 due to a decline in the U.S. dollar exchange rate. · Net change in cash for 2002 was SEK - 0.1 million (compared to SEK - 2.3 million for 2001). Biora develops, manufactures and sells biotechnology-based products to dentists. Its principal product, Emdogain®Gel, which is approved for sale in Europe, North America and Japan among others, naturally regenerates the tooth-supporting structure that the tooth has lost due to periodontitis. Biora's shares are listed on the "O-list" of the Stockholm Stock Exchange in Sweden. ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2003/02/13/20030213BIT00620/wkr0001.doc http://www.waymaker.net/bitonline/2003/02/13/20030213BIT00620/wkr0002.PDF